Hemorrhagic complications in urgently hospitalized patients with severe novel coronavirus infection COVID-19

Abstract

The purpose of this work was to study the features of the development of hemorrhagic complications in patients with bilateral viral pneumonia associated with COVID-19 of severe course, delivered to the hospital for emergency indications. The study included 561 patients with bilateral viral pneumonia. Various variants of bleeding were noted in 45 cases, all of them occurred in patients with severe new coronavirus infection (39 patients or 6.95% of all patients with severe NCI and 4.11% among all examined patients). Cases of combined hemorrhagic events were noted in 4 patients. In addition to age, gender, obesity and comorbidity, the use of antiplatelet therapy played a key role in the development of bleeding, which indicates the need to reduce the daily doses of such drugs at the later stages of treatment.